Redeye: IDL Biotech - Opportunity at a discount
We provide a short research update with the latest financial estimates and valuation following IDL Biotech’s Q1’19 report.
Read more and download the research update: http://bit.ly/2L10CWY
Start following companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se/about/